ASXL1 mutations in primary and secondary myelofibrosis

被引:15
|
作者
Ricci, Clara [1 ]
Spinelli, Orietta [1 ]
Salmoiraghi, Silvia [1 ]
Finazzi, Guido [1 ]
Carobbio, Alessandra [1 ]
Rambaldi, Alessandro [1 ]
机构
[1] Osped Riuniti Bergamo, Unit Haematol, I-24100 Bergamo, Italy
关键词
ASXL1; mutations; myelofibrosis; chronic myeloproliferative neoplasms; CHRONIC MYELOMONOCYTIC LEUKEMIA; MYELODYSPLASTIC SYNDROMES; MYELOPROLIFERATIVE NEOPLASMS; GENE ASXL1;
D O I
10.1111/j.1365-2141.2011.08865.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:404 / 407
页数:4
相关论文
共 50 条
  • [1] Genomic analysis of primary and secondary myelofibrosis redefines the prognostic impact of ASXL1 mutations: a FIM study
    Paz, Damien Luque
    Riou, Jeremie
    Verger, Emmanuelle
    Cassinat, Bruno
    Chauveau, Aurelie
    Ianotto, Jean-Christophe
    Dupriez, Brigitte
    Boyer, Francoise
    Renard, Maxime
    Mansier, Olivier
    Murati, Anne
    Rey, Jerome
    Etienne, Gabriel
    Mansat-De Mas, Veronique
    Tavitian, Suzanne
    Nibourel, Olivier
    Girault, Stephane
    Le Bris, Yannick
    Girodon, Francois
    Ranta, Dana
    Chomel, Jean-Claude
    Cony-Makhoul, Pascale
    Sujobert, Pierre
    Robles, Margot
    Ben Abdelali, Raouf
    Kosmider, Olivier
    Cottin, Laurane
    Roy, Lydia
    Sloma, Ivan
    Vacheret, Fabienne
    Wemeau, Mathieu
    Mossuz, Pascal
    Slama, Borhane
    Cussac, Vincent
    Denis, Guillaume
    Walter-Petrich, Anouk
    Burroni, Barbara
    Jezequel, Nathalie
    Giraudier, Stephane
    Lippert, Eric
    Socie, Gerard
    Kiladjian, Jean-Jacques
    Ugo, Valerie
    BLOOD ADVANCES, 2021, 5 (05) : 1442 - 1451
  • [2] Mutation Landscape and Prognostic Correlates of ASXL1 Variants in Primary and Secondary Myelofibrosis
    Coltro, Giacomo
    Guglielmelli, Paola
    Rotunno, Giada
    Mannarelli, Carmela
    Maccari, Chiara
    Salvadori, Costanza
    Vanderwert, Fiorenza Irushani
    Mannelli, Francesco
    Salvati, Cristina
    Vannucchi, Alessandro
    BLOOD, 2021, 138
  • [3] Spectrum of ASXL1 mutations in primary myelofibrosis: prognostic impact of the ASXL1 p.G646Wfs☆12 mutation
    Rotunno, Giada
    Mannarelli, Carmela
    Brogi, Giada
    Pacilli, Annalisa
    Gesullo, Francesca
    Mannelli, Francesco
    Fiaccabrino, Sara
    Sordi, Benedetta
    Paoli, Chiara
    Marone, Ilaria
    Rumi, Elisa
    Manfredini, Rossella
    Barosi, Giovanni
    Cazzola, Mario
    Vannucchi, Alessandro M.
    Guglielmelli, Paola
    BLOOD, 2019, 133 (26) : 2802 - 2808
  • [4] GENE EXPRESSION PROFILE IN PRIMARY MYELOFIBROSIS: ROLE OF ASXL1
    Sanchez Sosa, S.
    Bilbao Sieyro, C.
    Florido Ortega, Y.
    Gonzalez Perez, E.
    Saez Perdomo, M. N.
    Stuckey, R.
    Santana Santana, G.
    Molero Labarta, M. T.
    Loro Ferrer, J. F.
    Gomez Casares, M. T.
    HAEMATOLOGICA, 2019, 104 : 248 - 248
  • [5] The role of ASXL1 mutations and ASXL1 CircRNAs in cancer
    Jafarbeik-Iravani, Narges
    Kolahdozan, Sara
    Esmaeili, Rezvan
    BIOMARKERS, 2024, 29 (01) : 1 - 6
  • [6] ASXL1 Mutations in AML: Molecular Biomarker for Secondary AML?
    Hsu, Jingmei
    Kumar, Anita
    Carroll, Martin
    Frey, Noelle
    Shah, Nirav
    Zhao, Jianhua
    Hexner, Elizabeth
    Loren, Alison
    Perl, Alexander
    Porter, David
    Morrissette, Jennifer
    Luger, Selina
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 : S195 - S195
  • [7] ASXL1 Mutations in AML: Molecular Biomarker for Secondary AML?
    Hsu, Jingmei
    Kumar, Anita J.
    Carroll, Martin P.
    Frey, Noelle V.
    Shah, Nirav N.
    Jianhua, Zhao
    Hexner, Elizabeth O.
    Loren, Alison W.
    Mangan, James K.
    Perl, Alexander E.
    Porter, David
    Morrissette, Jennifer
    Luger, Selina M.
    BLOOD, 2014, 124 (21)
  • [8] CALR and ASXL1 mutations-based molecular prognostication in primary myelofibrosis: an international study of 570 patients
    Tefferi, A.
    Guglielmelli, P.
    Lasho, T. L.
    Rotunno, G.
    Finke, C.
    Mannarelli, C.
    Belachew, A. A.
    Pancrazzi, A.
    Wassie, E. A.
    Ketterling, R. P.
    Hanson, C. A.
    Pardanani, A.
    Vannucchi, A. M.
    LEUKEMIA, 2014, 28 (07) : 1494 - 1500
  • [9] CALR and ASXL1 mutations-based molecular prognostication in primary myelofibrosis: an international study of 570 patients
    A Tefferi
    P Guglielmelli
    T L Lasho
    G Rotunno
    C Finke
    C Mannarelli
    A A Belachew
    A Pancrazzi
    E A Wassie
    R P Ketterling
    C A Hanson
    A Pardanani
    A M Vannucchi
    Leukemia, 2014, 28 : 1494 - 1500
  • [10] Impact of ASXL1 Mutations On Outcome After Reduced Intensity Allograft in Patients with Myelofibrosis
    Kroeger, Nicolaus
    Koenecke, Christian
    Alchalby, Haefaa
    Zabelina, Tatjana
    Bollin, Robin
    Gehlhaar, Marten
    Dobbernack, Vera
    Kade, Sofia
    Huang, Liu
    Ganser, Arnold
    Ayuk, Francis
    Wolschke, Christine
    Thol, Felicitas
    Heuser, Michael
    BLOOD, 2012, 120 (21)